Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Obesity Agent”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38
Not applicableLooking for participantsNCT06945016
What this trial is testing

Monitoring Nutritional Consequences of Obesity Treatment on Women's Health

Who this might be right for
Obesity and Obesity-related Medical ConditionsBariatric SurgeryAnti-obesity Agents+6 more
Wageningen University and Research 1,150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331
What this trial is testing

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Who this might be right for
Hormone-receptor-positive Breast CancerEarly Breast Cancer
Universitaire Ziekenhuizen KU Leuven 168
Post-approval studies (Phase 4)Looking for participantsNCT05975580
What this trial is testing

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Who this might be right for
Obesity
University of California, Irvine 120
Not applicableLooking for participantsNCT07653412
What this trial is testing

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Who this might be right for
Obesity (Disorder)Anti-obesity AgentsPrecision Medicine
National and Kapodistrian University of Athens 220
Large-scale testing (Phase 3)Study completedNCT03336086
What this trial is testing

Effect of Weight Reduction on Immunity

Who this might be right for
LymphocytesWeight LossViral Diseases+2 more
Shiraz University of Medical Sciences 29
Early research (Phase 1)Study completedNCT02259179
What this trial is testing

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Who this might be right for
Healthy
Orexigen Therapeutics, Inc 80
Large-scale testing (Phase 3)WithdrawnNCT06619015
What this trial is testing

Tailoring Obesity Treatment Trial

Who this might be right for
ObesityAppetite RegulationPreDiabetes
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicableStudy completedNCT00108524
What this trial is testing

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Who this might be right for
Diabetes MellitusObesity
US Department of Veterans Affairs 146
Post-approval studies (Phase 4)Study completedNCT01090141
What this trial is testing

Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers

Who this might be right for
ObesityNutrition DisordersOverweight
University of Texas Southwestern Medical Center 36
Testing effectiveness (Phase 2)WithdrawnNCT00735683
What this trial is testing

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

Who this might be right for
Obesity
Healios K.K.
Not applicableStudy completedNCT05451927
What this trial is testing

Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

Who this might be right for
Overweight and Obesity
Hafiza Aisha Sadiqa 72
Very early researchTemporarily pausedNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT00822705
What this trial is testing

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Who this might be right for
Anti Obesity Agent
University Hospital, Basel, Switzerland 16
Very early researchLooking for participantsNCT07065591
What this trial is testing

Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity

Who this might be right for
Osteoarthritis (OA) of the Knee
The University of Hong Kong 100
Not applicableStudy completedNCT04901052
What this trial is testing

Effects of n-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects With Obesity

Who this might be right for
Obesity
University of Guadalajara 58
Not applicableStudy completedNCT07588750
What this trial is testing

Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice

Who this might be right for
Obesity & Overweight
Falquetomed 278
Not applicableLooking for participantsNCT06431308
What this trial is testing

Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events

Who this might be right for
Obesity; Drug
Ariel University 120
Early research (Phase 1)Ended earlyNCT01044108
What this trial is testing

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 117
Next Page